How to appeal a Humana vascular & endovascular — aaa, carotid, pad, varicose veins, ivc filters denial

The framework that applies to your appeal

Medicare Advantage plans follow a separate appeal track from commercial plans. Reconsideration must be requested within 60 days; if the plan misses its deadline, the case auto-forwards to the IRE (Maximus).

Humana-specific note: Heavily Medicare Advantage focused. MA-specific appeal track (42 CFR Part 422 Subpart M) applies — 60 days to request reconsideration, NOT the 180 days for commercial plans. Auto-forward to IRE (Maximus) if Humana misses deadline.

What Humana's policy requires for vascular & endovascular — aaa, carotid, pad, varicose veins, ivc filters

Cited policy: Humana Medicare Advantage — defers to CMS coverage and SVS / ACR appropriateness criteria for IVC filter

Documented VTE (acute DVT or PE) AND anticoagulation contraindication (active major bleeding, recent neurosurgery, severe thrombocytopenia) OR anticoagulation failure (recurrent VTE despite therapeutic AC). Retrievable filter preferred with documented retrieval plan. PE prophylaxis in selected high-risk surgical patients per SVS / ACCP.

How Humana denies vascular & endovascular — aaa, carotid, pad, varicose veins, ivc filters — and how to counter it

Where Humana pushes back: 1) AC contraindication not documented; 2) Filter placed 'prophylactically' without VTE; 3) No retrieval plan for retrievable filter; 4) Indication 'soft' (e.g. recent surgery alone).

Counter-arguments that hold up: Document specific AC contraindication (active GIB, intracranial hemorrhage, recent craniotomy / spine surgery) or failure (recurrent PE despite therapeutic INR / anti-Xa). Cite SVS Reporting Standards for IVC filter and PRESERVE registry outcomes. Document retrieval plan in chart with target date. For prophylactic placement cite specific high-risk indication per SVS / ACCP guidance and explicit anticipated AC contraindication.

What Humana typically denies for vascular & endovascular — aaa, carotid, pad, varicose veins, ivc filters

Across Humana's commercial and Medicare books, denials cluster around a small number of patterns. For vascular & endovascular — aaa, carotid, pad, varicose veins, ivc filters, expect:

• MA plan step therapy on Part B drugs
• Skilled nursing facility days
• Prior auth on specialty drugs
• OON emergency reduction

Treatments most often denied in this category

These are the vascular & endovascular — aaa, carotid, pad, varicose veins, ivc filters treatments most often flagged for prior auth, step therapy, or medical necessity review:

• EVAR (AAA)
• F-EVAR / B-EVAR
• Open AAA repair
• TEVAR
• CEA
• CAS (transfemoral)

How to submit the appeal to Humana

1. Read the denial letter — note the exact denial reason code and the appeal deadline (60 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Humana cited in the denial.
3. File the appeal through Humana's portal (members: https://www.humana.com ; providers: https://www.humana.com/provider). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In KY, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Humana's prior-authorization criteria by drug: Humana PA criteria on ApprovalHelp.